Presentation is loading. Please wait.

Presentation is loading. Please wait.

Autologous mitochondrial transfer as a complementary technique to intracytoplasmic sperm injection to improve embryo quality in patients undergoing in.

Published byAudrey Douglas Modified over 5 years ago

Similar presentations

Presentation on theme: "Autologous mitochondrial transfer as a complementary technique to intracytoplasmic sperm injection to improve embryo quality in patients undergoing in."— Presentation transcript:

1 Autologous mitochondrial transfer as a complementary technique to intracytoplasmic sperm injection to improve embryo quality in patients undergoing in vitro fertilization—a randomized pilot study  Elena Labarta, M.D., Ph.D., Maria José de los Santos, Ph.D., Sonia Herraiz, Ph.D., Maria José Escribá, Ph.D., Alicia Marzal, M.D., Anna Buigues, B.Sc., Antonio Pellicer, M.D.  Fertility and Sterility  Volume 111, Issue 1, Pages (January 2019) DOI: /j.fertnstert Copyright © 2018 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 (A) Schematic drawing representing the complete procedure. (B) Study flow diagram. Oocytes from the same patient were randomized to receive either conventional ICSI or AUGMENT. Comparisons were made between embryos coming from both groups. AUGMENT = autologous mitochondrial transfer; ET = embryo transfer; MII = metaphase II; ICSI = intracytoplasmic sperm injection; mtDNA = mitochondrial DNA; PGT-A = preimplantation genetic testing for aneuploidy. Fertility and Sterility  , 86-96DOI: ( /j.fertnstert ) Copyright © 2018 American Society for Reproductive Medicine Terms and Conditions

3 Figure 1 (A) Schematic drawing representing the complete procedure. (B) Study flow diagram. Oocytes from the same patient were randomized to receive either conventional ICSI or AUGMENT. Comparisons were made between embryos coming from both groups. AUGMENT = autologous mitochondrial transfer; ET = embryo transfer; MII = metaphase II; ICSI = intracytoplasmic sperm injection; mtDNA = mitochondrial DNA; PGT-A = preimplantation genetic testing for aneuploidy. Fertility and Sterility  , 86-96DOI: ( /j.fertnstert ) Copyright © 2018 American Society for Reproductive Medicine Terms and Conditions

4 Figure 2 (A) Day 5 blastocyst formation rate per zygote obtained in Control and AUGMENT groups. (B) ASEBIR score of embryos on day 5 of development. ASEBIR = Association for the Study of Reproductive Biology; other abbreviations as in Figure 1. Fertility and Sterility  , 86-96DOI: ( /j.fertnstert ) Copyright © 2018 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Autologous mitochondrial transfer as a complementary technique to intracytoplasmic sperm injection to improve embryo quality in patients undergoing in."

Similar presentations

A time to look back: analysis of morphokinetic characteristics of human embryo development  Javier Herrero, Ph.D., Alberto Tejera, Ph.D., Carmela Albert,

A time to look back: analysis of morphokinetic characteristics of human embryo development  Javier Herrero, Ph.D., Alberto Tejera, Ph.D., Carmela Albert,
Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human.

Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human.
Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H. 

Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H. 
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication  Thamara Viloria,

Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication  Thamara Viloria,
Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro.

Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro.
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Relationship between pre-embryo pronuclear morphology (zygote score) and standard day 2 or 3 embryo morphology with regard to assisted reproductive technique.

Relationship between pre-embryo pronuclear morphology (zygote score) and standard day 2 or 3 embryo morphology with regard to assisted reproductive technique.
Successful delivery after the transfer of embryos obtained from a cohort of incompletely in vivo matured oocytes at retrieval time  Patricia Fauque, M.D.,

Successful delivery after the transfer of embryos obtained from a cohort of incompletely in vivo matured oocytes at retrieval time  Patricia Fauque, M.D.,
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 

Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 
Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day.

Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day.
Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph

Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 

A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
A prospective randomized controlled trial of preimplantation genetic screening in the “good prognosis” patient  Liza R. Meyer, M.S., Sigal Klipstein,

A prospective randomized controlled trial of preimplantation genetic screening in the “good prognosis” patient  Liza R. Meyer, M.S., Sigal Klipstein,
Konstantinos Pantos, M. D. , Evangelos Makrakis, M. D

Konstantinos Pantos, M. D. , Evangelos Makrakis, M. D
Live birth of twins derived from zona-free oocytes

Live birth of twins derived from zona-free oocytes
Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis  Juan Wen, B.S., Jie Jiang, B.S.,

Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis  Juan Wen, B.S., Jie Jiang, B.S.,
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

Similar presentations

Ads by Google